Joint Filing AgreementJoint Filing Agreement • July 19th, 2012 • Victory Park Capital Advisors, LLC • Medicinal chemicals & botanical products
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock of Unigene Laboratories, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 18th day of July, 2012.
REDEMPTION AGREEMENTRedemption Agreement • July 19th, 2012 • Victory Park Capital Advisors, LLC • Medicinal chemicals & botanical products
This Redemption Agreement (this “Agreement”), dated July 16, 2012, is by and between Victory Park Credit Opportunities, L.P., a Delaware limited partnership (“VPCO”), and Victory Park Credit Opportunities Master Fund, Ltd., a Cayman Islands exempted company (the “Master Fund”).
REDEMPTION AGREEMENTRedemption Agreement • July 19th, 2012 • Victory Park Capital Advisors, LLC • Medicinal chemicals & botanical products
This Redemption Agreement (this “Agreement”), dated July 16, 2012, is by and between Victory Park Credit Opportunities Intermediate Fund, L.P., a Cayman Islands exempted limited partnership (“VPCOIF”), and Victory Park Credit Opportunities Master Fund, Ltd., a Cayman Islands exempted company (the “Master Fund”).
